Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita)
Clinical trial NCT04240210 · TERMINATED
Trial details
- NCT number
- NCT04240210
- Sponsor
- Midland Research Group, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-17
- Primary completion
- 2021-12-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.